Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › KRSNAA

KRSNAA

Krsnaa Diagnostics Limited
Micro-capPharma ↗

What the six lenses say about KRSNAA — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹564.0
2026-09-08
VWAP · 1Y anchor
₹682
-17.3% from VWAP
P/E · TTM
18.0×
TTM EPS ₹31.3
52-week range
13%
position low→high
RSI(14)
54
momentum

Own sector index

Pharma ↗
Overweight

1M

+0.4%

3M

+10.5%

1Y

+22.0%

Breadth >EMA21

56%

How KRSNAA’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
6.0
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Micro-cap cohortDRaw
TechnicalD553›

The actual numbers

Price vs VWAP (1y)-17.3%
EMA trend stackMixed
Price vs 200-EMA-8.5%
Price vs 50-EMA+1.3%
RSI(14)54
RS vs Nifty 500 · 3M+0.9%
RS vs sector · 3M-5.1%
52-week range13%
Volume vs 30d avg1.00×
Volume vs 60d avg1.16×
ATR(14) · volatility18.1
Bollinger width · vol contraction0.071
FundamentalD645›

The actual numbers

Return on equity (ROE)10.4%
Operating margin21.3%
Net margin13.2%
Revenue growth · YoY+7.8%
EPS growth · YoY+30.1%
Debt / equity0.54×

Full 8-quarter history in the financials table below.

ValuationD966›

The actual numbers

P/E (TTM)18.0×
TTM EPS₹31.3
52-week range13%
CatalystD742›

The actual numbers

Earnings & momentum39
Capital actions18
Governance98

Every filing in the corporate-announcements panel below.

FlowD750›

The actual numbers

Promoter holding27.1%
Delivery · 30d avg58.1%
Up/down-day asymmetry1.2pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D5 + D7 ) ÷ 2 = 6.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Medium
52
Conviction score 52/100 · avg-decile strength 6.0/10
Conviction score52/100›
TechnicalD5›
FundamentalD6›
ValuationD9›
CatalystD7›
FlowD7›

Policy

Government policy · Pharma

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+1.2pp
+3.1pp
+4.2pp
+2.5pp
-4.9pp
-27.9pp
Nifty 500
Broad-market baseline
+1.1pp
+3.1pp
+3.2pp
+0.9pp
-10.6pp
-33.1pp
Sector
Own-sector index
—
—
+0.3pp
-5.1pp
-23.7pp
-53.9pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

KRSNAA daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
564.05+4.05

Relative strength

RS vs baseline · rebased to 100

KRSNAA ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
75.14+0.85

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)170186175186193206181193
↳ change QoQ—+9.5%-6.3%+6.6%+3.8%+6.7%-12.1%+6.6%
EBITDA (₹cr)5054545351594655
EBITDA margin29.4%29.0%31.1%28.5%26.4%28.6%25.4%28.5%
PAT (₹cr)1820192121241542
↳ change QoQ—+9.3%-0.9%+8.2%+0.0%+14.3%-37.5%+180.0%
Net margin10.5%10.5%11.1%11.3%10.9%11.7%8.3%21.8%
EPS (₹)5.556.076.016.406.337.384.7012.86
D/E————————
YoY growth · Mar '26Revenue +3.8% YoYPAT +100.0% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 9 Sep '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 28 Aug '26
    LOWgovernance
    Corrigendum
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 26 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 19 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 14 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 14 Aug '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 13 Aug '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 13 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 13 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 7 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 23 Jul '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 29 Jun '26
    MEDIUMcapital
    Credit Rating
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds KRSNAA

Mutual funds holding KRSNAA (1)

FundWeightAUM ₹crGrade
Tata Small Cap Fund Reg Gr1.08%12,696

ETFs holding KRSNAA (0)

No tracked ETF holds KRSNAA ≥0.5%.

Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Pharma